Clinical Trials Directory

Trials / Completed

CompletedNCT01341535

Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.

A Two-arm Phase II Randomized Study, Comparing Adaptive Biological Imaging - Voxel Intensity - Based Radiotherapy (Adaptive Dose Escalation) Versus Standard Radiotherapy for Head and Neck Cancer.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that treatment adaptation to biological and anatomical changes, occurring during treatment, can increase the chance of cure at minimized or equal radiation-induced toxicity in head and neck cancer patients. This trial compares standard intensity-modulated radiotherapy (IMRT), using only pre-treatment planning 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to adaptive 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography voxel intensity based IMRT or volumetric-modulated arc therapy (VMAT) using repetitive per-treatment planning 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography for head and neck cancer.

Conditions

Interventions

TypeNameDescription
RADIATIONAdaptive dose-painting-by-numbersAdaptive dose escalation by dose-painting-by-numbers.
RADIATIONstandard intensity-modulated radiotherapy (IMRT)Standard radiotherapy for head and neck cancer.

Timeline

Start date
2011-09-01
Primary completion
2017-10-31
Completion
2021-07-15
First posted
2011-04-25
Last updated
2022-12-14

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01341535. Inclusion in this directory is not an endorsement.